Second Opinion

20141 hr, 16 mins
96%
4%

The War on Cancer, launched in the early 1970s, set the stage for a massive influx of new ideas for fighting the disease. Memorial Sloan-Kettering Cancer Center, America's leading cancer research center at the time, was assigned the task of testing an unconventional therapy called “Laetrile” in an effort to curb the public’s “false hope” in the alleged “quack” therapy.

Ralph W. Moss PhD, a young and eager science writer, was hired by Sloan-Kettering’s public relations department in 1974 to help brief the American public on the center’s contribution to the War on Cancer. He discovered that studies suggesting the possible efficacy of Laetrile were being squelched. So he summoned the courage to go public and blow the whistle.

107Bookmarks
6Comments